<unk>  is a thrombopoietin receptor agonist that is FDA approved for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.   Common adverse reactions include pyrexia, abdominal pain, nausea, headache, fatigue, and edema peripheral.
Avatrombopag
Lusutrombopag
Otamixaban
Eltrombopag
Reteplase
Ximelagatran
Anistreplase
Argatroban